Bortezomib linked to low risk of heart failure in multiple myeloma patients Healio NEW ORLEANS— Jacob P. Laubach, MD, MPP, from the division of hematologic malignancies at the Dana-Farber Cancer Institute, presents data from a retrospective analysis of data which identified that bortezomib was associated with a low rate of grade 3 ... |
